Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50016248
TargetFibroblast growth factor receptor 1(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878)
Affinity DataIC50: 0.470nMAssay Description:Inhibition of FGFR1 (unknown origin) in presence of ATP at Km concentration by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of FGFR2 (unknown origin) in presence of ATP at Km concentration by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593524(CHEMBL5206147)
Affinity DataIC50: 1nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593525(CHEMBL5182060)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593522(CHEMBL5170802)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593521(CHEMBL5182779)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593530(CHEMBL5201061)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593526(CHEMBL5197399)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593520(CHEMBL5194555)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593532(CHEMBL5193271)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593523(CHEMBL5171147)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593533(CHEMBL5207973)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593527(CHEMBL5191170)
Affinity DataIC50: 2nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878)
Affinity DataIC50: 2.10nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593529(CHEMBL5197909)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of FGFR3 (unknown origin) in presence of ATP at Km concentration by mobility shift assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593528(CHEMBL5189378)
Affinity DataIC50: 4.5nMAssay Description:Inhibition of wild type N-terminal GST tagged FGFR3 (436 to 806 residues) (unknown origin) expressed in sf21 insect cells preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593521(CHEMBL5182779)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593525(CHEMBL5182060)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593523(CHEMBL5171147)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593522(CHEMBL5170802)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593520(CHEMBL5194555)
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593524(CHEMBL5206147)
Affinity DataIC50: 7.60E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593526(CHEMBL5197399)
Affinity DataIC50: 8.10E+3nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593531(Asp 5878 | Asp-5878 | Asp5878 | ASP-5878 | ASP5878)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50559408(CHEMBL4763773)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593528(CHEMBL5189378)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593527(CHEMBL5191170)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593529(CHEMBL5197909)
Affinity DataIC50: 8.30E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50593530(CHEMBL5201061)
Affinity DataIC50: 8.90E+4nMAssay Description:Inhibition of hERG channel expressed in CHO cells at -80 mV holding potential by Qpatch clamp methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2023
Entry Details
PubMed